The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
10x Genomics, Inc. | CL A COM | 88025u109 | 14,831,603 | 359,554 | SH | SOLE | 359,554 | 0 | 0 | |||
Aadi Bioscience, Inc. | COM | 00032Q104 | 2,547,432 | 526,329 | SH | SOLE | 526,329 | 0 | 0 | |||
Adicet Bio, Inc. | COM | 007002108 | 274,275 | 200,201 | SH | SOLE | 200,201 | 0 | 0 | |||
Alpine Immune Sciences, Inc. | COM | 02083G100 | 76,809,898 | 6,708,288 | SH | SOLE | 6,708,288 | 0 | 0 | |||
Pyxis Oncology, Inc (formerly Apexigen) | COM | 747324101 | 650,352 | 326,810 | SH | SOLE | 326,810 | 0 | 0 | |||
AtriCure Inc. | COM | 04963C209 | 2,026,144 | 46,259 | SH | SOLE | 46,259 | 0 | 0 | |||
Arcus Biosciences, Inc | COM | 03969F109 | 15,612,731 | 869,790 | SH | SOLE | 869,790 | 0 | 0 | |||
Argenx SE | SHS | 04016x101 | 13,484,919 | 27,429 | SH | SOLE | 27,429 | 0 | 0 | |||
Aura Biosciences, Inc. | COM | 05153U107 | 18,243,928 | 1,163,123 | SH | SOLE | 1,163,123 | 0 | 0 | |||
BeyondSpring Inc. | SHS | G10830100 | 3,966,514 | 4,958,143 | SH | SOLE | 4,958,143 | 0 | 0 | |||
Cue Health Inc. | COM | 229790100 | 3,969,798 | 8,980,909 | SH | SOLE | 8,980,909 | 0 | 0 | |||
Equillium Inc. | COM | 29446K106 | 3,291,008 | 4,447,308 | SH | SOLE | 4,447,308 | 0 | 0 | |||
Horizon Therapeutics PLC | COM | G46188101 | 9,127,941 | 78,900 | SH | SOLE | 78,900 | 0 | 0 | |||
Illumnia, Inc. | COM | 452327109 | 11,100,324 | 80,859 | SH | SOLE | 80,859 | 0 | 0 | |||
Mersana Therapeutics, Inc. | COM | 59045L106 | 1,148,420 | 904,268 | SH | SOLE | 904,268 | 0 | 0 | |||
Pacific Biosciences of California, Inc. | COM | 69404D108 | 12,223,331 | 1,463,872 | SH | SOLE | 1,463,872 | 0 | 0 | |||
Scynexis Inc. | COM NEW | 811292200 | 1,266,665 | 555,555 | SH | SOLE | 555,555 | 0 | 0 | |||
GeneDx Holdings Corp. | COM CL A | 81663L200 | 377,118 | 103,604 | SH | SOLE | 103,604 | 0 | 0 | |||
Terns Pharmaceuticals, Inc. | COM | 880881107 | 3,592,854 | 714,285 | SH | SOLE | 714,285 | 0 | 0 | |||
Zentalis Pharmaceuticals Inc. | COM | 98943L107 | 42,117,635 | 2,099,583 | SH | SOLE | 2,099,583 | 0 | 0 | |||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 8,814,500 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | |||
ROIVANT SCIENCES LTD | COM | G76279101 | 17,049,296 | 1,459,700 | SH | SOLE | 1,459,700 | 0 | 0 | |||
ACELYRIN INC(NSM) | COM | 00445A100 | 15,746,384 | 1,548,317 | SH | SOLE | 1,548,317 | 0 | 0 | |||
IMMUNOGEN INC | COM | 45253H101 | 6,600,016 | 415,880 | SH | SOLE | 415,880 | 0 | 0 | |||
LANTHEUS HOLDINGS INC(NMS) | COM | 516544103 | 9,879,778 | 142,196 | SH | SOLE | 142,196 | 0 | 0 | |||
SEAGEN INC | COM | 81181C104 | 4,882,420 | 23,014 | SH | SOLE | 23,014 | 0 | 0 | |||
Everest Medicines Limited | COM | 44975P103 | 13,313,230 | 4,166,667 | SH | SOLE | 4,166,667 | 0 | 0 |